Fresenius Kabi Oncology Limited strives to provide state-of-the-art third generation chemotherapeutic drugs right from development to manufacturing & marketing across the globe. It is all set to become a leading player in Oncology generics by virtue of a comprehensive product portfolio of injectables, oral cytotoxics, cytostatics, intermediates and active pharmaceutical ingredients (APIs). Fresenius Kabi Oncology Limited product portfolio and manufacturing facilities are being endorsed by world's leading regulatory authorities.